2023
DOI: 10.1016/j.jos.2022.03.012
|View full text |Cite
|
Sign up to set email alerts
|

Japanese Orthopaedic Association (JOA) Clinical practice guidelines on the Management of Cervical Spondylotic Myelopathy,2020 – Secondary publication

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
8
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(11 citation statements)
references
References 0 publications
0
8
0
Order By: Relevance
“…The Japanese Orthopedic Association (JOA) scale 8 was used to evaluate preoperative neurological impairment and postoperative recovery.…”
Section: Methodsmentioning
confidence: 99%
“…The Japanese Orthopedic Association (JOA) scale 8 was used to evaluate preoperative neurological impairment and postoperative recovery.…”
Section: Methodsmentioning
confidence: 99%
“…We prospectively recruited all consecutive patients who underwent C3-C7 laminoplasty for CSM at our institution between October 2020 and September 2021. The inclusion and exclusion criteria were determined based on the Japanese Orthopaedic Association Clinical practice guidelines on the Management of Cervical Spondylotic Myelopathy, 2020 23. The inclusion criteria were (1) patients with multilevel CSM manifesting in some combination of clinical findings, such as bilateral hand clumsiness and numbness, unsteady gait, weakness in the limbs, muscular dystrophy, hyperreflexia, or positive Hoffmann and Babinski signs; (2) indicated for a C3-C7 laminoplasty because of significant spinal compression indicated by magnetic resonance imaging (MRI), and had persistent neurological symptoms and signs for at least three months, which are not cured by conservative treatment or still progressing despite such treatment; and (3) willingness to participate in the study and sign the informed consent form.…”
Section: Methodsmentioning
confidence: 99%
“…The inclusion and exclusion criteria were determined based on the Japanese Orthopaedic Association Clinical practice guidelines on the Management of Cervical Spondylotic Myelopathy, 2020. 23 The inclusion criteria were (1) patients with multilevel CSM manifesting in some combination of clinical findings, such as bilateral hand clumsiness and numbness, unsteady gait, weakness in the limbs, muscular dystrophy, hyperreflexia, or positive Hoffmann and Babinski signs; (2) indicated for a C3-C7 laminoplasty because of significant spinal compression indicated by magnetic resonance imaging (MRI), and had persistent neurological symptoms and signs for at least three months, which are not cured by conservative treatment or still progressing despite such treatment; and (3) willingness to participate in the study and sign the informed consent form. The exclusion criteria were (1) patients with a pattern of anterior spinal cord compression that was not a good indication for C3-C7 laminoplasty alone, ossification of the posterior longitudinal ligament (OPLL), and disk herniation; (2) previous surgery for CSM, active infection, neoplastic disease, rheumatoid arthritis, ankylosing spondylitis, trauma, and concomitant symptomatic lumbar spinal stenosis; and (3) inability to comply with the study because of severe psychosis.…”
Section: Study Populationmentioning
confidence: 99%
“…CSM mainly occurs due to intervertebral disc degeneration, bulging posterior elements, and spinal instability resulting from age-related degenerative changes, while OPLL has a genetic background 1) . The severity of DCM is commonly assessed by the Nurick scale, Japanese Orthopaedic Association (JOA) score, or modified JOA score from the medical providers' perspective 2) . Contrarily, patient-oriented tools for assessing DCM severity vary from the simplest visual analog scale (VAS), the 36-Item Short-Form Health Survey and the EuroQol-5 Dimensions for assessing general health-related quality of life, the Neck Disability Index for patients with neck pain, and the Myelopathy Disability Index and the European Myelopathy Scale to assess highly specific scales for cervical myelopathy 2) .…”
Section: Introductionmentioning
confidence: 99%
“…The severity of DCM is commonly assessed by the Nurick scale, Japanese Orthopaedic Association (JOA) score, or modified JOA score from the medical providers' perspective 2) . Contrarily, patient-oriented tools for assessing DCM severity vary from the simplest visual analog scale (VAS), the 36-Item Short-Form Health Survey and the EuroQol-5 Dimensions for assessing general health-related quality of life, the Neck Disability Index for patients with neck pain, and the Myelopathy Disability Index and the European Myelopathy Scale to assess highly specific scales for cervical myelopathy 2) . The JOA Cervical Myelopathy Assessment Questionnaire (JOACMEQ), originally developed to measure clinical outcomes in patients with cervical myelopathy 3,4) , has also been reported as a reliable tool for surgical outcomes of the cervical spine 5) .…”
Section: Introductionmentioning
confidence: 99%